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Background: Charcot–Marie–Tooth (CMT) disease is a hereditary neuropathy associ-
ated with impaired walking capacity. Some patients are too weak in the lower extrem-
ity muscles to walk at gravity with sufficient intensity or duration to gain benefit.
Aim: The aim was to investigate the effect of aerobic anti-gravity exercise in weak 
patients	with	CMT	1A	and	X.
Methods:	 Five	 adult	 patients	 performed	 moderate-	intensity	 aerobic	 anti-gravity	
 exercise 3/week for 10 weeks.
Results: There was a significant positive difference in Berg balance scale and postural 
stability	 test	 between	 test	 occasions,	 and	walking	 distance	 in	 the	 6-	min	walk	 test	
trended to increase.
Conclusions: The study indicates that the anti-gravity treadmill training of patients 
with CMT should be pursued in larger CMT cohorts.
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1  | INTRODUCTION








gravity at sufficient intensity or duration to obtain benefit. This is 
possible	on	an	anti-gravity	treadmill,	which	off	lifts	load	on	the	lower	
extremities.
The objective was to investigate the effect of aerobic anti-gravity 





and 2016. Inclusion criteria were as follows: (1) genetically verified CMT 
type	1A	or	X,	 (2)	≥18	years,	and	 (3)	walking	ability	≥10	m.	Exclusion	





The study consisted of a 10- week normal daily lives control period 
followed by a 10- week supervised exercise period with walking or 
running	3/week	for	30	min,	consisting	of	5	min	warm-	up	and	25	min	




The primary outcome was the 6MWT. The secondary outcomes were 
(1) postural stability test—overall (PST; Biosway Portable Balance 
System	950-	460),	(2)	clinical	test	of	sensory	integration	and	balance	
(CT-	SIB;	Biosway	Portable	Balance	System	950-	460),	 (3)	 fatigue	se-
verity	scale	 (FSS),	 (4)	short	form	(36)	health	survey	(SF-	36),	 (5)	Berg	
balance	scale	(BBS),	and	(6)	fitness	(Berthelsen	et	al.,	2014).
2.4 | Statistical analyses
Sample size calculations were performed using PS: Power and Sample 
Size	 Calculation	 version	 3.1.2,	 2014	 (Dupont	 &	 Plummer,	 1990).	
Statistics were performed in SPSS Statistics 22. Parametric and non-
parametric analyses were applied as appropriate for intention- to- treat 
(ITT) and per protocol (PP) analyses. ITT analysis was performed on 
the patients from Table 1 who had more than one exercise session. 






Patient characteristics are described in Table 1. Ten patients were re-
cruited,	 and	 five	 patients	withdrew	 (see	Data	 S2).	One	 patient	 lost	
balance	during	anti-gravity	exercise,	but	completed	the	exercise.	No	
serious adverse events were reported. There was no significant dif-
ference	between	completers	and	dropouts	regarding	age,	body	mass	
index	(BMI),	and	muscle	strength	(p	≥	.267).	Based	on	sample	size	cal-
culations the study was underpowered (see Data S2).
ITT analysis showed a statistically significant difference between 
baseline,	pretest,	midtest,	and	posttest	for	BBS	and	PST,	but	6MWT	
only	trended	to	 increase	 (Figure	1,	Table	2).	The	other	outcomes	did	
not change significantly (see data for all outcomes in Table 3).
4  | DISCUSSION
This small pilot study showed a significant positive change in  balance 
and a trend toward improvement in walking capacity with anti-
gravity	treadmill	training	in	CMT.	This	was	so,	even	though	a	priori	
power calculation suggested a need for including six patients. Post 
hoc analysis of BBS showed a significant difference between baseline 
and	posttest	only,	which	indicates	that	the	difference	was	not	solely	
caused	by	 the	 intervention.	For	PST,	post	hoc	analysis	was	unable	
to detect where the difference between measurements was. This is 





use of aid Sensory symptoms
Muscle strength (Nm) (hip flex/
ext, knee flex/ext, ankle 
plantarflex/dorsalflex)
Physical activity 
(hours last 7 days)a Status
Patient	1/CMT1A F/62/27 N/none AB	toesb,c,d,e 31/58,	32/60,	6/0 0/0/0/91 Drop out
Patient	2/CMT1A M/53/28 N/none AB	toesb,c,d,e 33/37,	25/69,	48/0 0/0/6/49 Completed
Patient	3/CMTX M/64/21 N/ankle foot 
orthoses






























     |  3 of 5KNAK et Al.
ITT	 and	 PP	 analyses	 showed	 similar	 results	 for	 all	 outcomes,	
except for BBS (ITT p	=	.021,	 PP	 p = .121). ITT is more conser-
vative,	 thus,	 it	 is	more	difficult	 to	detect	 a	possible	effect,	 but	 the	
result might be explained by dropouts that reduce the power in PP 
compared to ITT.
One patient increased the walking distance in the 6MWT with 
approximately 100 m between each test occasion from baseline to 
posttest,	which	is	a	remarkably	difference	questioning	the	credibility	of	
the	results.	The	patient’s	post-	HR	after	6MWT	was	similar	for	baseline,	
pre-	,	 and	midtest	 (post-	HR:	 114–117),	 but	 increased	 substantially	 at	
posttest	 (post-	HR:	167).	Thus,	at	 least	some	of	the	increased	walking	














Baseline–pretest 17 ± 17 0	(−6;8) 0	(−.5;.3)
Baseline–midtest 71	±	38 4	(0;5) −.2	(−.7;0)
Baseline–posttest 92	±	53 3 (2;12) −.2	(−.6;0)
Pretest–midtest 54	±	25 4	(0;5) −.2	(−.4;0)
Pretest–posttest 75	±	39 8	(1;10) −.1	(−.4;0)
Midtest–posttest 21 ± 16 2 (0;6) 0 (0;.1)
6MWT,	6-	min	walk	test	(m);	BBS,	Berg	balance	scale	(score);	PST,	postural	
stability	test	(index);	ITT,	intention-	to-	treat	analysis.
aMean ± standard error of the mean.
bMedian	(25th;75th	percentile).
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The	 temporary	 pain	 in	 two	 patients	 might	 be	 due	 to	 overload,	





and Maggi et al. (2011) indicated that walking on a normal tread-
mill	 combined	 with	 stretching,	 respiratory,	 and	 proprioceptive	
exercises improved walking capacity without overwork weakness 
in CMT. Berthelsen et al. (2014) showed effect of anti-gravity 
strength and aerobic exercises on walking capacity and balance in 




temporary	 pain.	 Thus,	 further	 studies	 are	 needed	 to	 assess	 the	
true magnitude of the effect of anti-gravity training in patients 
with marked muscle weakness.






gesting that anti-gravity treadmill training of hereditary neuropathies 
should be pursued in a larger cohort of patients.
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